The findings suggest that dysregulated FBN1/asprosin signaling is associated with neuroinflammatory pathways and serotoninergic dysfunction which coincide with disruptions in maternal care and bonding mechanisms during GDM. This evidence concerns the gene FBN1 and gestational diabetes.